Question

The nurse is collaborating with another nurse about the client's plan of care. For each potential provider's prescription, click to specify if the potential prescription is anticipated or contraindicated for the client.

Option 1: Anticipated

Transvaginal ultrasound
Option 2: Contraindicated

Meperidine IM
Option 3: Anticipated

Repeat quantitative β-hCG level
Option 4: Contraindicated

Methotrexate IM
Option 5: Anticipated

Blood typing

Answer 1

When developing a client's plan of care, treatments such as Transvaginal ultrasound, repeating β-hCG levels, and blood typing are anticipated, whereas Meperidine IM and Methotrexate IM may be contraindicated, depending on the client's condition and test outcomes.

Step-by-step explanation:

When collaborating with another nurse on the client's plan of care, it is essential to determine which prescribed treatments are appropriate for the client's condition. Based on the clinical context provided, here is how one might evaluate the potential prescriptions:

• Anticipated: A Transvaginal ultrasound may be expected to assess pelvic structures or monitor an early pregnancy.
• Contraindicated: Meperidine IM might be contraindicated due to potential side effects or the client's specific health status.
• Anticipated: Repeating the quantitative β-hCG level can be necessary for monitoring the status of a pregnancy.
• Contraindicated: Methotrexate IM may be contraindicated if the client is pregnant, as it can be harmful to the developing fetus.
• Anticipated: Blood typing is generally anticipated as it is critical for identifying blood group for potential transfusions or during pregnancy to assess risks for Rh incompatibility.

It is vital to continuously evaluate the client's plan of care and make adjustments based on ongoing assessments and test results to ensure the best possible outcomes for the client.